The relationship between medical information, real-world evidence (RWE), and marketing in the pharmaceutical industry is interconnected and plays a crucial role in the development, approval, and commercialization of new treatments.
Post-marketing surveillance (PMS) is crucial in veterinary products to ensure continued safety and efficacy after a product has been approved and is on the market.
In Latin America, particularly in Mexico and Brazil, pharmacovigilance has gained relevance in recent decades due to increasing access to medicines and the need to ensure their safety and efficacy.
The process of bringing a drug from the laboratory to the market is complex and highly regulated. Preparing regulatory packages, interacting with regulatory agencies, and post-launch compliance are critical stages to ensure the safety and efficacy of the product.
The United States Food and Drug Administration (FDA) plays a crucial role in protecting and regulating the food, drug, medical device, biologic, and cosmetic industries in the United States.